Kolon Life Science Inc. (KOSDAQ:102940)

Kolon Life Science Statistics

Total Valuation

KOSDAQ:102940 has a market cap or net worth of KRW 303.75 billion. The enterprise value is 417.85 billion.

Market Cap	303.75B
Enterprise Value	417.85B

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:102940 has 12.42 million shares outstanding. The number of shares has increased by 4.65% in one year.

Current Share Class	12.42M
Shares Outstanding	12.42M
Shares Change (YoY)	+4.65%
Shares Change (QoQ)	+0.51%
Owned by Insiders (%)	18.06%
Owned by Institutions (%)	0.24%
Float	6.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.88
PB Ratio	2.03
P/TBV Ratio	2.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.49
EV / Sales	2.59
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-18.76

Financial Position

The company has a current ratio of 0.49, with a Debt / Equity ratio of 0.85.

Current Ratio	0.49
Quick Ratio	0.24
Debt / Equity	0.85
Debt / EBITDA	n/a
Debt / FCF	-5.68
Interest Coverage	-2.98

Financial Efficiency

Return on equity (ROE) is -64.87% and return on invested capital (ROIC) is -5.29%.

Return on Equity (ROE)	-64.87%
Return on Assets (ROA)	-3.79%
Return on Invested Capital (ROIC)	-5.29%
Return on Capital Employed (ROCE)	-10.35%
Revenue Per Employee	384.25M
Profits Per Employee	-221.63M
Employee Count	420
Asset Turnover	0.44
Inventory Turnover	2.53

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.64% in the last 52 weeks. The beta is -0.30, so KOSDAQ:102940's price volatility has been lower than the market average.

Beta (5Y)	-0.30
52-Week Price Change	+9.64%
50-Day Moving Average	28,955.00
200-Day Moving Average	23,265.20
Relative Strength Index (RSI)	32.74
Average Volume (20 Days)	25,595

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:102940 had revenue of KRW 161.39 billion and -93.09 billion in losses. Loss per share was -7,794.19.

Revenue	161.39B
Gross Profit	16.74B
Operating Income	-22.08B
Pretax Income	-93.09B
Net Income	-93.09B
EBITDA	-13.21B
EBIT	-22.08B
Loss Per Share	-7,794.19

Balance Sheet

The company has 12.50 billion in cash and 126.60 billion in debt, giving a net cash position of -114.10 billion or -9,184.28 per share.

Cash & Cash Equivalents	12.50B
Total Debt	126.60B
Net Cash	-114.10B
Net Cash Per Share	-9,184.28
Equity (Book Value)	149.34B
Book Value Per Share	12,020.68
Working Capital	-104.20B

Cash Flow

In the last 12 months, operating cash flow was -14.08 billion and capital expenditures -8.19 billion, giving a free cash flow of -22.28 billion.

Operating Cash Flow	-14.08B
Capital Expenditures	-8.19B
Free Cash Flow	-22.28B
FCF Per Share	-1,793.32

Margins

Gross margin is 10.37%, with operating and profit margins of -13.68% and -57.68%.

Gross Margin	10.37%
Operating Margin	-13.68%
Pretax Margin	-57.68%
Profit Margin	-57.68%
EBITDA Margin	-8.18%
EBIT Margin	-13.68%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:102940 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.65%
Shareholder Yield	-4.65%
Earnings Yield	-30.65%
FCF Yield	-7.33%

Stock Splits

The last stock split was on December 27, 2017. It was a forward split with a ratio of 1.5.

Last Split Date	Dec 27, 2017
Split Type	Forward
Split Ratio	1.5

Scores

KOSDAQ:102940 has an Altman Z-Score of -0.27. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.27
Piotroski F-Score	n/a